Literature DB >> 23677335

Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children.

D Tomizawa1, A Tawa, T Watanabe, A M Saito, K Kudo, T Taga, S Iwamoto, A Shimada, K Terui, H Moritake, A Kinoshita, H Takahashi, H Nakayama, K Koh, H Kigasawa, Y Kosaka, H Miyachi, K Horibe, T Nakahata, S Adachi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23677335     DOI： 10.1038/leu.2013.153

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  18 in total

1.  Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Authors:  Ilaria Iacobucci; Ji Wen; Manja Meggendorfer; John K Choi; Lei Shi; Stanley B Pounds; Catherine L Carmichael; Katherine E Masih; Sarah M Morris; R Coleman Lindsley; Laura J Janke; Thomas B Alexander; Guangchun Song; Chunxu Qu; Yongjin Li; Debbie Payne-Turner; Daisuke Tomizawa; Nobutaka Kiyokawa; Marcus Valentine; Virginia Valentine; Giuseppe Basso; Franco Locatelli; Eric J Enemark; Shirley K Y Kham; Allen E J Yeoh; Xiaotu Ma; Xin Zhou; Edgar Sioson; Michael Rusch; Rhonda E Ries; Elliot Stieglitz; Stephen P Hunger; Andrew H Wei; L Bik To; Ian D Lewis; Richard J D'Andrea; Benjamin T Kile; Anna L Brown; Hamish S Scott; Christopher N Hahn; Paula Marlton; Deqing Pei; Cheng Cheng; Mignon L Loh; Benjamin L Ebert; Soheil Meshinchi; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2019-03-29       Impact factor: 38.330

2.  Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

Authors:  M Tokumasu; C Murata; A Shimada; K Ohki; Y Hayashi; A M Saito; J Fujimoto; K Horibe; M Nagao; H Itoh; Y Kamikubo; H Nakayama; A Kinoshita; D Tomizawa; T Taga; A Tawa; S Tanaka; T Heike; S Adachi
Journal:  Leukemia       Date:  2015-05-15       Impact factor: 11.528

3.  Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.

Authors:  Norio Shiba; Kenichi Yoshida; Yusuke Hara; Genki Yamato; Yuichi Shiraishi; Hidemasa Matsuo; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Taeko Kaburagi; Masanobu Takeuchi; Kentaro Ohki; Masashi Sanada; Jun Okubo; Daisuke Tomizawa; Tomohiko Taki; Akira Shimada; Manabu Sotomatsu; Keizo Horibe; Takashi Taga; Souichi Adachi; Akio Tawa; Satoru Miyano; Seishi Ogawa; Yasuhide Hayashi
Journal:  Blood Adv       Date:  2019-10-22

4.  Residual disease detected by multidimensional flow cytometry shows prognostic significance in childhood acute myeloid leukemia with intermediate cytogenetics and negative FLT3-ITD: a report from the Tokyo Children's Cancer Study Group.

Authors:  Dai Keino; Akitoshi Kinoshita; Daisuke Tomizawa; Hiroyuki Takahashi; Kohmei Ida; Hidemitsu Kurosawa; Kazutoshi Koike; Setsuo Ota; Noriyuki Iwasaki; Junya Fujimura; Yuki Yuza; Chikako Kiyotani; Shohei Yamamoto; Tomoo Osumi; Takahiro Ueda; Shinji Mochizuki; Keiichi Isoyama; Ryoji Hanada; Akio Tawa; Atsushi Manabe; Yoichi Toguchi; Akira Ohara
Journal:  Int J Hematol       Date:  2016-01-18       Impact factor: 2.490

5.  Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.

Authors:  Daisuke Tomizawa; Tomoyuki Watanabe; Ryoji Hanada; Keizo Horibe; Yasuo Horikoshi; Shotaro Iwamoto; Akitoshi Kinoshita; Hiroshi Moritake; Hideki Nakayama; Akira Shimada; Takashi Taga; Hiroyuki Takahashi; Akio Tawa; Kiminori Terui; Hiroki Hori; Yoshifumi Kawano; Atsushi Kikuta; Atsushi Manabe; Souichi Adachi
Journal:  Int J Hematol       Date:  2015-07-01       Impact factor: 2.490

6.  Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.

Authors:  Takashi Taga; Toshihiko Imamura; Kentaro Nakashima; Naoko Maeda; Akihiro Watanabe; Yuji Miyajima; Sachi Sakaguchi; Hitoshi Sano; Daiichiro Hasegawa; Hirohide Kawasaki; Souichi Adachi; Masatoshi Takagi; Katsuyoshi Koh; Atsushi Manabe; Tomohiko Taki; Yasushi Ishida
Journal:  Int J Hematol       Date:  2018-07-03       Impact factor: 2.490

7.  High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS).

Authors:  Hisanori Fujino; Hiroyuki Ishida; Akihiro Iguchi; Masaei Onuma; Koji Kato; Mariko Shimizu; Masahiro Yasui; Hiroyuki Fujisaki; Kazuko Hamamoto; Kana Washio; Hirotoshi Sakaguchi; Emiko Miyashita; Yuko Osugi; Etsuko Nakagami-Yamaguchi; Akira Hayakawa; Atsushi Sato; Yoshiyuki Takahashi; Keizo Horibe
Journal:  Int J Hematol       Date:  2019-03-12       Impact factor: 2.490

Review 8.  Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia.

Authors:  C Michel Zwaan; Edward A Kolb; Dirk Reinhardt; Jonas Abrahamsson; Souichi Adachi; Richard Aplenc; Eveline S J M De Bont; Barbara De Moerloose; Michael Dworzak; Brenda E S Gibson; Henrik Hasle; Guy Leverger; Franco Locatelli; Christine Ragu; Raul C Ribeiro; Carmelo Rizzari; Jeffrey E Rubnitz; Owen P Smith; Lillian Sung; Daisuke Tomizawa; Marry M van den Heuvel-Eibrink; Ursula Creutzig; Gertjan J L Kaspers
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

9.  Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia.

Authors:  Hidemasa Matsuo; Kenichi Yoshida; Kazutaka Fukumura; Kana Nakatani; Yuki Noguchi; Saho Takasaki; Mina Noura; Yusuke Shiozawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Ai Okada; Yasuhito Nannya; June Takeda; Hiroo Ueno; Norio Shiba; Genki Yamato; Hiroshi Handa; Yuichiro Ono; Nobuhiro Hiramoto; Takayuki Ishikawa; Kensuke Usuki; Ken Ishiyama; Shuichi Miyawaki; Hidehiro Itonaga; Yasushi Miyazaki; Machiko Kawamura; Hiroki Yamaguchi; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Yasuhide Hayashi; Hiroyuki Mano; Satoru Miyano; Yasuhiko Kamikubo; Seishi Ogawa; Souichi Adachi
Journal:  Blood Adv       Date:  2018-11-13

10.  Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML.

Authors:  Hidemasa Matsuo; Kenichi Yoshida; Kana Nakatani; Yutarou Harata; Moe Higashitani; Yuri Ito; Yasuhiko Kamikubo; Yusuke Shiozawa; Yuichi Shiraishi; Kenichi Chiba; Hiroko Tanaka; Ai Okada; Yasuhito Nannya; June Takeda; Hiroo Ueno; Nobutaka Kiyokawa; Daisuke Tomizawa; Takashi Taga; Akio Tawa; Satoru Miyano; Manja Meggendorfer; Claudia Haferlach; Seishi Ogawa; Souichi Adachi
Journal:  Blood Adv       Date:  2020-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.